Machado Patrick

Xenon Pharmaceuticals Inc. · Director

Machado Patrick is listed in public filings as director. This Machado Patrick insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Xenon Pharmaceuticals Inc. (XENE), Adverum Biotechnologies, Inc. (ADVM), Alumis Inc. Common Stock (ALMS), Arcus Biosciences, Inc. (RCUS), and Acelyrin, Inc. (SLRN). Investors use Machado Patrick's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Xenon Pharmaceuticals Inc.XENE$562k10.5k sharesGrant / ExerciseJun 3, 2026$561.7K10.5k shares$53.46--
Xenon Pharmaceuticals Inc.XENE--1.6k sharesGrant / ExerciseJun 3, 2026Disclosure amount unavailable1.6k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Xenon Pharmaceuticals Inc.XENE--2.6k sharesGrant / ExerciseJun 1, 2026Disclosure amount unavailable2.6k shares----
Adverum Biotechnologies, Inc.ADVM$03k sharesOtherDec 9, 2025$769.2K3k shares$256.40--
Adverum Biotechnologies, Inc.ADVM$04.5k sharesOtherDec 9, 2025$603.5K4.5k shares$134.10--
Adverum Biotechnologies, Inc.ADVM$03.5k sharesOtherDec 9, 2025$218.8K3.5k shares$62.50--
Adverum Biotechnologies, Inc.ADVM$05.3k sharesOtherDec 9, 2025$194.3K5.3k shares$37.00--
Adverum Biotechnologies, Inc.ADVM$01.5k sharesOtherDec 9, 2025$172.8K1.5k shares$115.20--
Adverum Biotechnologies, Inc.ADVM$013.8k sharesOtherDec 9, 2025$101.2K13.8k shares$7.32--
Adverum Biotechnologies, Inc.ADVM$03.4k sharesOtherDec 9, 2025$92.4K3.4k shares$27.50--
Adverum Biotechnologies, Inc.ADVM$05.3k sharesOtherDec 9, 2025$81.9K5.3k shares$15.60--
Adverum Biotechnologies, Inc.ADVM$01k sharesOtherDec 9, 2025$64.0K1k shares$64.00--
Adverum Biotechnologies, Inc.ADVM$05.3k sharesOtherDec 9, 2025$52.0K5.3k shares$9.90--
Adverum Biotechnologies, Inc.ADVM$013.6k sharesOtherDec 9, 2025$31.5K13.6k shares$2.32--
Adverum Biotechnologies, Inc.ADVM$08.8k sharesOtherDec 9, 2025$31.4K8.8k shares$3.56--
Alumis Inc. Common StockALMS$204k49.8k sharesGrant / ExerciseJul 30, 2025$204.2K49.8k shares$4.10--
Adverum Biotechnologies, Inc.ADVM$24k10.5k sharesGrant / ExerciseJun 17, 2025$24.2K10.5k shares$2.32--
Adverum Biotechnologies, Inc.ADVM$7.3k3.1k sharesGrant / ExerciseJun 17, 2025$7.3K3.1k shares$2.32--
Arcus Biosciences, Inc.RCUS$384k38.3k sharesGrant / ExerciseJun 10, 2025$383.8K38.3k shares$10.02--
Arcus Biosciences, Inc.RCUS--38.6k sharesGrant / ExerciseJun 10, 2025Disclosure amount unavailable13.3k shares----
Xenon Pharmaceuticals Inc.XENE$523k17k sharesGrant / ExerciseJun 5, 2025$522.8K17k shares$30.73--
Xenon Pharmaceuticals Inc.XENE--2.6k sharesGrant / ExerciseJun 5, 2025Disclosure amount unavailable2.6k shares----
Alumis Inc. Common StockALMS$507k41.5k sharesGrant / ExerciseMay 21, 2025$506.7K41.5k shares$12.21--
Acelyrin, Inc.SLRN$086.2k sharesOtherMay 21, 2025$506.6K86.2k shares$5.88--
Acelyrin, Inc.SLRN$023.2k sharesOtherMay 21, 2025$418.4K23.2k shares$18.00--
Alumis Inc. Common StockALMS$418k11.2k sharesGrant / ExerciseMay 21, 2025$418.4K11.2k shares$37.39--
Acelyrin, Inc.SLRN$092.2k sharesOtherMay 21, 2025$411.0K92.2k shares$4.46--
Alumis Inc. Common StockALMS$411k44.4k sharesGrant / ExerciseMay 21, 2025$410.8K44.4k shares$9.26--
Acelyrin, Inc.SLRN$014.7k sharesOtherMay 21, 2025Disclosure amount unavailable14.7k shares$0.00--
Alumis Inc. Common StockALMS$07.1k sharesGrant / ExerciseMay 21, 2025Disclosure amount unavailable7.1k shares$0.00--
Alumis Inc. Common StockALMS$169k13.8k sharesGrant / ExerciseMay 21, 2025$168.5K13.8k shares$12.21--
Alumis Inc. Common StockALMS$31k19.5k sharesGrant / ExerciseMay 21, 2025$31.2K19.5k shares$1.60--
Acelyrin, Inc.SLRN$040.6k sharesOtherMay 21, 2025$31.2K40.6k shares$0.7683--
Adverum Biotechnologies, Inc.ADVM$77k10.5k sharesGrant / ExerciseJun 17, 2024$77.0K10.5k shares$7.32--
Adverum Biotechnologies, Inc.ADVM$24k3.3k sharesGrant / ExerciseJun 17, 2024$24.2K3.3k shares$7.32--